The Prevalence and Risk Factors for Symptomatic Dry Eye in Adults in Riyadh, Saudi Arabia

Abstract

Objectives:

The objective of this study is to estimate the prevalence of symptomatic suspected dry eye, diagnosed dry eye syndrome (DES), and associated risk factors; in Riyadh, Saudi Arabia.

Methods:

A cross-sectional study of 654 participants was employed using a self-administered semi-structured questionnaire that included demographic characteristics like age, gender, and risk factors (smoking, using contact lenses, chronic comorbidities, etc.).

Results:

There were 266 (40.7%) previously diagnosed DES participants and 388 (59.3%) non-diagnosed DES, of which 497 were female and 157 were male. Females had a significantly higher rate of diagnosed DES than males (p<0.001), with a significant increase in the rate of DES diagnosis with age (p<0.001). There was also a significant increase in DES in participants with diabetes mellitus, allergic eye, thyroid eye, and skin diseases, as well as having undergone laser surgery or using contact lenses. There was no significant increase in DES in cases of smoking, daily use of electronic devices, or duration of sleep.

Conclusion:

The prevalence of dry eye among adults in Riyadh was 46.6%, with the most important risk factors being female gender, increasing age, Lasik refractive surgery, skin disease around the eye, and thyroid eye disease.

Keywords: Contact lenses, Dry eye, Lasik refractive surgery, Risk factors, Riyadh region, Contact lenses, Skin diseases.

1. INTRODUCTION

Dry eye syndrome (DES) is a common chronic disease of the ocular surface [1, 2]. The primary components of tears are mucin, aqueous, and lipid layers, which combine to create a complex viscoelastic structure. The lacrimal and accessory lacrimal glands produce the aqueous layer, the goblet cells of the conjunctiva produce the mucin layer, and the meibomian glands produce the lipid layer. This complex structure is responsible for lubrication nutrition as well as protecting the cornea. The lipid layer prevents evaporation and stabilizes tears Deficiency of any of the three layers may lead to symptoms of DES [3].

DES has significant socio-economic implications, such as increased healthcare costs and a negative impact on vision-related quality of life issues, such as driving, television watching, reading, computer work, and emotional wellbeing [4]. The validated six-item questionnaire of ocular symptoms related to dry eye [5, 6] is a widely used effective tool to assess the presence of dry eye; nonetheless, the prevalence of DES is difficult to assess due to the variability and inconsistency of symptoms, methods of diagnosis, and a poor link between symptoms and signs frequently encountered in other eye conditions [7]. Consequently, the prevalence may be underestimated [8-10], varying widely between studies, regions, and countries. However, despite the high prevalence of DES, no cure is available; therefore, early recognition and prevention are important to improve patients' symptoms with primary preventive measures such as education and elimination of risk factors.

This study aimed to estimate the prevalence of diagnosed and symptomatic suspected DES and its relation to risk factors in adults in Riyadh, Saudi Arabia.

2. MATERIALS AND METHODS

This cross-sectional study of Saudi adults (>18 years) in Riyadh, Saudi Arabia used a self-administered semi-structured questionnaire designed to cover the symptoms and signs of dry eye. This study was conducted from November 2019 to March 2020 and included 654 participants. Participants were included in the study provided they completed all components of the questionnaire, which included informed consent. The questionnaire included demographic characteristics like age and gender, as well as risk factors (smoking, using contact lenses, chronic comorbidities, etc.). In addition, the questionnaire included multiple lifestyle factors that were hypothesized to be associated with DES.

A validated six-item questionnaire of ocular symptoms related to the dry eye has been used for the assessment of DES [5, 6]. This questionnaire was developed as a patient-centered self-assessment to assist healthcare providers in diagnosing DES and assessing the symptoms of the syndrome, feeling sandy sensation, burning eyes, red eyes, crusting on lashes, stuck eyes, and feeling dry or uncomfortable with air conditioning. The frequency of a symptom was scored as never, rarely (at least once in 3-4 months), sometimes (once in 2-4 weeks), often (at least once a week), or constantly (all the time).

2.1. Ethical Considerations

Participants provided informed consent. Confidentiality of the responses was maintained strictly to ensure the privacy of their data and protect their anonymity. The participants had the right to withdraw from the study at any time. The study adhered to the guidelines of the Declaration of Helsinki.

2.2. Data Analysis

A participant was considered positive if they were previously diagnosed as DES and complained of at least one symptom of DES sometimes, often, or constantly, or if they were previously undiagnosed DES but complained of at least one symptom of DES often or constantly. Data were expressed as numbers and percentages, and statistical analyses were performed using the Statistical Package for the Social Sciences software, version 19.0 (SPSS Inc, Chicago, IL, USA). The chi-square test was used to compare groups.

3. RESULTS

A total of 654 questionnaires were completed in this study. There were 497 female respondents and 157 male respondents, of which 266 (40.7%) were previously diagnosed as DES and 388 (59.3%) were not diagnosed as DES. The demographic and clinical data of the participants are shown in Table (1). Females had a significantly higher rate of diagnosed DES than male participants (p<0.001), with a significant increase in the rate of diagnosis of DES with age (p<0.001). There was also a significant increase in DES in those participants with allergic or thyroid eye disease, diabetes mellitus, and skin diseases or those having undergone laser surgery or using contact lenses, whereas smoking, daily use of electronic devices, or sleeping duration had no impact on DES diagnosis (Table 1).

Table 1.
Demographic and clinical data of 654 participants of non-diagnosed dry eye syndrome (DES) (n=388) and diagnosed DES (n=266).
Characteristics Non-Diagnosed DES, n (%) Diagnosed DES, n (%) P-value*
Gender
   Female, n = 498 (76.15%) 275 (70.88%) 223 (83.83%)
   Male, n = 156 (23.85%) 113 (29.12%) 43 (16.17%) <0.001
Age
   18 to 29 yrs, n = 158 (24.16%) 116 (29.90%) 42 (15.79%)
   30 to 40 yrs, n = 154 (23.55%) 91 (23.45%) 63 (23.68%)
   >40 yrs, n = 342 (52.29%) 181 (46.65%) 161 (60.53%) <0.001
Allergic eye disease
   No, n = 486 (74.31%) 325 (83.76%) 161 (60.53%)
   Yes, n = 168 (25.69%) 63 (16.24%) 105 (39.47%) <0.001
Lasik surgery
   No, n = 504 (77.06%) 315 (81.19%) 189 (71.05%)
   Yes, n = 150 (22.94%) 73 (18.81%) 77 (28.95%) 0.002
Using contact lenses
   No, n = 544 (83.18%) 332 (85.57%) 212 (79.70%)
   Yes, n = 110 (16.82%) 56 (14.43%) 54 (20.30%) 0.048
Using electronic devices
   <2 hrs, n = 49 (7.49%) 31 (7.99%) 18 (6.77%)
   2-4 hrs, n = 260 (39.76%) 148 (38.14%) 112 (42.11%)
   5-7 hrs, n = 228 (34.86%) 137 (35.31%) 91 (34.21%)
   >7 hrs, n = 117 (17.89%) 72 (18.56%) 45 (16.92%) 0.746
Sleeping hours
   5-7 hrs, n = 496 (75.84%) 284 (73.20%) 212 (79.70%)
   8-10 hrs, n = 158 (24.16%) 104 (26.80%) 54 (20.30%) 0.056
Skin disease
   No, n = 589 (90.06%) 369 (95.10%) 220 (82.71%)
   Yes, n = 65 (9.94%) 19 (4.90%) 46 (17.29%) <0.001
Diabetes Mellitus
   No, n = 566 (86.54%) 346 (89.17%) 220 (38.87%)
   Yes, n = 88 (13.4%) 42 (10.82%) 46 (52.27%) 0.017
Thyroid disease
   No, n = 566 (86.54%) 348 (61.48%) 218 (81.95%)
   Yes, n = 88 (13.46%) 40 (45.45%) 48 (18.05%) 0.004
Smoking
   No, n = 621 (94.95%) 365 (94.07%) 256 (96.24%)
   Yes, n = 33 (5.05%) 23 (5.93%) 10 (3.76%) 0.213

* χ2

In diagnosed DES, 116 participants (43.6%) reported experiencing one or more symptoms often or constantly: one symptom in 51 participants (19.2%), two symptoms in 30 participants (11.3%), three symptoms in 21 participants (7.9%), four symptoms in 7 participants (2.6%), five symptoms in 6 participants (2.6%), and 6 symptoms (all symptoms) in 1 participant (0.4%). The symptoms reported included burning sensation (60 participants; 22.6%), feeling uncomfortable with AC (59 participants; 22.2%), stuck eyes (41 participants; 15.1%), red eyes (37 participants; 13.9%), sandy sensation (28 participants; 10.5%), and crusting on the eyelashes (24 participants; 9.0%) (Table 2). The distribution of symptoms of dry eye in participants diagnosed with DES is illustrated in Fig. (1). In previously non-diagnosed DES, 56 participants (14.4%) reported experiencing one or more symptoms often or constantly (Table 3), with an overall 172/654 (26.3%). The distribution of dry eye symptoms in participants non-diagnosed as DES is illustrated in Fig. (2). The age and sex distribution among diagnosed DES are shown in Fig. (3). The most infrequent symptoms reported as often or constantly were crusting on eyelashes and stuck eyes in the morning. Seventeen participants of the previously diagnosed DES group reported symptoms as never or rare only; hence, they were considered negative participants for DES, and the remaining 249 were considered positive for DES. Fifty-six participants of the previously non-diagnosed DES group reported one or more symptoms as often or constantly and were considered positive for DES; hence there were 305/654 (46.64%) positive participants.

Table 2.
Symptoms of dry eye in 266 participants diagnosed as having dry eye syndrome [n (%)].
- Never Rare Sometimes Often Constantly
Sandy sensation 60 (22.56%) 45 (16.92%) 133 (%) 25 (%) 3 (%)
Burning sensation 27 (10.15%) 45 (16.92%) 134 (50.38%) 50 (18.80%) 10 (3.76%)
Red eye 48 (18.05%) 80 (30.08%) 101 (37.97%) 34 (12.78%) 3 (1.13%)
Crusting on eye lashes 147 (55.26%) 49 (18.42%) 46 (17.29%) 19 (7.14%) 5 (1.88%)
Stuck eyes in the morning 110 (41.35%) 54 (20.30%) 61 (22.93%) 31 (11.65%) 10 (3.77%)
Feeling uncomfortable with AC 76 (28.57%) 58 (21.80%) 83 (31.20%) 32 (12.03%) 17 (6.39%)
Table 3.
Symptoms of dry eye in 388 participants not suffering from dry eye syndrome [n (%)].
- Never Rare Sometimes Often Constantly
Sandy sensation 181 (46.65) 97 (25.00%) 103 (26.55%) 7 (1.80%) 0 (0.00%)
Burning sensation 148 (38.14%) 101 (26.03%) 124 (31.96%) 13 (3.36%) 2 (0.52%)
Red eye 126 (32.47%) 143 (36.86%) 102 (26.29%) 12 (3.09%) 5 (1.29%)
Crusting on eye lashes 309 (79.64%) 52 (13.40%) 24 (6.19%) 2 (0.52%) 1 (0.26%)
Stuck eyes in the morning 259 (66.75%) 72 (18.56%) 45 (11.60%) 10 (2.58%) 2 (0.52%)
Feeling uncomfortable with AC 210 (54.12%) 81 (20.88%) 72 (18.56%) 23 (5.93%) 2 (0.52%)
Fig. (1). Distribution of symptoms of dry eye in 266 participants diagnosed to have DES.
Fig. (2). Distribution of symptoms of dry eye in 388 participants not diagnosed to have DES.
Fig. (3). Age and sex distribution in 266 participants diagnosed as DED.

4. DISCUSSION

DES is an ocular surface disorder and represents one of the most common eye diseases [11]. It is a public health concern that causes significant health problems affecting visual function and quality of life. A key factor in the diagnosis of DES is identifying the risk factors and looking at the accurate and detailed medical history. DES is not associated with specific symptoms, and the symptoms may vary between individuals in terms of their type and severity. Furthermore, there may be no symptoms during the early stages of the disease. The prevalence of DES ranges from 6.8% to 87.5% [11-13].

In this study, there were 40.7% previously diagnosed DES participants, of whom 17 participants reported that they experienced symptoms never or rarely and were considered negative, indicating that the actual prevalence should depend on patient examination and tests for the dry eye rather than a self-reported questionnaire. Many participants (56 out of 388) with non-diagnosed DES having one or more symptoms of the dry eye constantly or often were suspected of having DES and considered positive for DES, thereby increasing the prevalence of DES. Consequently, the prevalence of DES in Riyadh is about 47%, one of the highest reported and may be related to the hot, dry climate in Riyadh, with residents frequently using air conditioners and fans at home and in cars. Factors affecting the variation in the prevalence of DES between studies may include the criteria of DES diagnosis, the climate, humidity, prevalence of trachoma, as well as the use of fans and air conditioners. A study conducted in AlHasa KSA in which DES was diagnosed based on the participants complaining of one or more symptoms of DES as often or constantly reported a prevalence of 32.1% (597 out of 1858) [14]. Similarly, in our study, the prevalence of participants complaining of one or more symptoms was 26.3%.

There was a significantly higher prevalence of dry eye in females than males, and this sex difference was consistent across all the age groups in the present study. This may be due to female sex hormones and their effect on the ocular surface and tear secretion, in line with other studies [12, 15-20]. Nonetheless, the sex difference consistent across all studied age groups, was not universal in previous studies [21-25].

Furthermore, aging was found to be a significant risk factor for DES as in other studies [15, 16, 18-20], possibly due to decreased tear secretion and blinking reflex that leads to increased evaporation of tears with increasing age. Also, participants with diabetes mellitus, skin disease around the eye, thyroid problems, and blepharitis were more prone to symptoms of dry eye.

5. LIMITATIONS

There are some limitations to this study; for instance, the diagnosis of dry eye was dependent on history and symptoms and signs, but no tests for DES were performed due to the COVID-19 pandemic. Also, the sample number for some items was too low for statistical analysis, e.g., smoking.

CONCLUSION

The prevalence of DES in Riyadh was 46.6%, with women being more susceptible to DES than men. Various factors were associated with an increased risk of DES, such as wearing contact lenses or having a history of vision corrected by Lasik, prolonged use of electronic devices, eye or surrounding skin allergy, as well as chronic diseases like diabetes and thyroid disease. Further studies with more participants are required, especially in summer, and it is important to conduct dry eye tests to better evaluate the prevalence of DES.

AUTHORS’ CONTRIBUTIONS

BHA: Supervision, Methodology, Software, Project administration. AAA 1: Literature review, Manuscript writing, Data collection, Reviewing, and Editing. AAA 2: Resources, Visualization. AAA 3: Investigation, Formal analysis. TWA: Literature review, Manuscript writing, Data collection, Reviewing, and Editing.

All authors have critically reviewed and approved the final draft and are responsible for the content and similarity index of the manuscript.

ETHICS APPROVAL AND CONSENT TO PARTICIPATE

The study design and protocol were approved by the local Institutional Review Board with the number: SUCOM/LIRB/2019-07.

HUMAN AND ANIMAL RIGHTS

No animals were used in this research. All human research procedures were in accordance with the ethical standards of the committee responsible for human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2013.

CONSENT FOR PUBLICATION

All participants were given an explanation of the aims and objectives of the study through the questionnaire published on the website that contained informed consent.

STANDARDS OF REPORTING

STROBE guidelines and methodologies were followed for this study.

AVAILABILITY OF DATA AND MATERIALS

The study data and materials are not publicly available due to the confidentiality and privacy of the participants.

FUNDING

None.

CONFLICT OF INTEREST

The authors declare no conflict of interest, financial or otherwise.

ACKNOWLEDGEMENTS

The authors are thankful to Shaqra University, Ministry of Education, Kingdom of Saudi Arabia, for providing a platform to encourage research and development among the students, staff, and society.

REFERENCES

1
Tong L, Waduthantri S, Wong TY, et al. Impact of symptomatic dry eye on vision-related daily activities: The Singapore Malay Eye Study. Eye (Lond) 2010; 24(9): 1486-91.
2
Seen S, Tong L. Dry eye disease and oxidative stress. Acta Ophthalmol 2018; 96(4): e412-20.
3
The epidemiology of dry eye disease: Report of the Epidemiology Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf 2007; 5(2): 93-107.
4
Pouyeh B, Viteri E, Feuer W, et al. Impact of ocular surface symptoms on quality of life in a United States veterans affairs population. Am J Ophthalmol 2012; 153(6): 1061-66.e3.
5
Bandeen-Roche K, Muñoz B, Tielsch JM, West SK, Schein OD. Self-reported assessment of dry eye in a population-based setting. Invest Ophthalmol Vis Sci 1997; 38(12): 2469-75.
6
Schein OD, Tielsch JM, Munõz B, Bandeen-Roche K, West S. Relation between signs and symptoms of dry eye in the elderly. A population-based perspective. Ophthalmology 1997; 104(9): 1395-401.
7
Sullivan BD, Crews LA, Messmer EM, et al. Correlations between commonly used objective signs and symptoms for the diagnosis of dry eye disease: Clinical implications. Acta Ophthalmol 2014; 92(2): 161-6.
8
Grubbs JR Jr, Tolleson-Rinehart S, Huynh K, Davis RM. A review of quality of life measures in dry eye questionnaires. Cornea 2014; 33(2): 215-8.
9
Miljanović B, Dana R, Sullivan DA, Schaumberg DA. Impact of dry eye syndrome on vision-related quality of life. Am J Ophthalmol 2007; 143(3): 409-15.
10
Uchino M, Schaumberg DA. Dry eye disease: Impact on quality of life and vision. Curr Ophthalmol Rep 2013; 1(2): 51-7.
11
Fenga C, Aragona P, Di Nola C, Spinella R. Comparison of ocular surface disease index and tear osmolarity as markers of ocular surface dysfunction in video terminal display workers. Am J Ophthalmol 2014; 158(1): 41-48.e2.
12
Farrand KF, Fridman M, Stillman IÖ, Schaumberg DA. Prevalence of diagnosed dry eye disease in the United States among adults aged 18 years and older. Am J Ophthalmol 2017; 182: 90-8.
13
Nakamura S, Kinoshita S, Yokoi N, et al. Lacrimal hypofunction as a new mechanism of dry eye in visual display terminal users. PLoS One 2010; 5(6)e11119
14
Alshamrani AA, Almousa AS, Almulhim AA, et al. Prevalence and risk factors of dry eye symptoms in a Saudi Arabian population. Middle East Afr J Ophthalmol 2017; 24(2): 67-73.
15
Schaumberg DA, Dana R, Buring JE, Sullivan DA. Prevalence of dry eye disease among US men: Estimates from the Physicians’ Health Studies. Arch Ophthalmol 2009; 127(6): 763-8.
16
Moss SE, Klein R, Klein BE. Long-term incidence of dry eye in an older population. Optom Vis Sci 2008; 85(8): 668-74.
17
Schaumberg DA, Sullivan DA, Buring JE, Dana MR. Prevalence of dry eye syndrome among US women. Am J Ophthalmol 2003; 136(2): 318-26.
18
Yazdani C, McLaughlin T, Smeeding JE, Walt J. Prevalence of treated dry eye disease in a managed care population. Clin Ther 2001; 23(10): 1672-82.
19
Galor A, Feuer W, Lee DJ, et al. Depression, post-traumatic stress disorder, and dry eye syndrome: A study utilizing the national United States Veterans Affairs administrative database. Am J Ophthalmol 2012; 154(2): 340-346.e2.
20
Schaumberg DA, Uchino M, Christen WG, Semba RD, Buring JE, Li JZ. Patient reported differences in dry eye disease between men and women: Impact, management, and patient satisfaction. PLoS One 2013; 8(9)e76121
21
Moss SE, Klein R, Klein BE. Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol 2000; 118(9): 1264-8.
22
Lekhanont K, Rojanaporn D, Chuck RS, Vongthongsri A. Prevalence of dry eye in Bangkok, Thailand. Cornea 2006; 25(10): 1162-7.
23
Moss SE, Klein R, Klein BE. Incidence of dry eye in an older population. Arch Ophthalmol 2004; 122(3): 369-73.
24
Lin P-Y, Tsai S-Y, Cheng C-Y, Liu J-H, Chou P, Hsu W-M. Prevalence of dry eye among an elderly Chinese population in Taiwan: The Shihpai Eye Study. Ophthalmology 2003; 110(6): 1096-101.
25
Song P, Xia W, Wang M, et al. Variations of dry eye disease prevalence by age, sex and geographic characteristics in China: A systematic review and meta-analysis. J Glob Health 2018; 8(2)020503